Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Australian Clinical Labs Ltd ( (AU:ACL) ).
Australian Clinical Labs Ltd has announced an update regarding its ongoing on-market buy-back of ordinary fully paid securities. As of the latest notification, the company has bought back a total of 4,274,630 securities, with 150,000 purchased on the previous day. This buy-back initiative may impact the company’s stock value and shareholder equity, reflecting a strategic move to manage capital and potentially enhance shareholder returns.
More about Australian Clinical Labs Ltd
Australian Clinical Labs Ltd operates in the healthcare industry, focusing on providing pathology services. The company is known for offering a range of diagnostic testing services across Australia, serving both private and public sectors.
YTD Price Performance: -7.65%
Average Trading Volume: 996,500
Technical Sentiment Signal: Hold
Current Market Cap: A$622.9M
Learn more about ACL stock on TipRanks’ Stock Analysis page.